Mr. Swanson is an American entrepreneur and investor focused on disruptive technologies with large addressable markets. He is former Co-Founder and Executive Vice Chairman of Flavocure Biotech, Inc., a drug discovery and research company focused on advancing treatment for oncology with research and trials based at Harvard’s Brigham and Women’s Hospital, Dana Farber Cancer Institute and Johns Hopkins. Most recently, Mr. Swanson served as start-up President, CEO, and Vice Chairman for Blockcap, Inc, a blockchain digital asset company acquired in June, 2021 as part of a $4.3 billion merger with Nasdaq listed Power & Digital Infrastructure (Nasdaq: XPDI) backed by Blackrock Private Investments Fund.
Swanson also is Co-Founder of Vilotos Pharmaceuticals, a virology company with research and development focused on Covid-19, HIV/AIDS, Hepatitis, and other viruses for which Mr. Swanson is a patent author and co-inventor. Mr. Swanson has served as Co-Founder, President & Chief Executive Officer and Director of Blackline Safety Corp., a preeminent (Deloitte Fastest 500, TSX 50, Profit 500 & IDC Top 10 to Watch) technology company publicly traded on the Toronto Stock Exchange.
